C83.30
Diffuse large B-cell lymphoma, unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma, a cancer that originates in the lymphatic system. It is characterized by the rapid growth of large B cells, which are a type of lymphocyte involved in the body's immune response. When diagnosed without specifying the site of involvement, it is classified under ICD-10 code C83.30. DLBCL can occur in various parts of the body, including lymph nodes and extranodal sites, and it is considered an aggressive form of lymphoma that requires prompt medical attention.
Causes & Symptoms
Clinical Causes: Genetic mutations within B cells Exposure to certain chemicals or pesticides Immunodeficiency conditions, such as HIV/AIDS Previous radiation therapy or chemotherapy Certain infections, such as Epstein-Barr virus or Helicobacter pylori
Key Symptoms: Swollen, painless lymph nodes in the neck, armpits, or groin Unexplained weight loss Fever that persists over time Night sweats Fatigue or weakness Shortness of breath or cough if the chest is involved Abdominal pain or swelling if the abdomen is affected
Diagnostic & Treatment
Diagnosis Path: - Additional tests, including bone marrow biopsies or molecular studies, may be performed to aid in staging and treatment planning
Treatment Protocols: - Supportive care to manage side effects and improve quality of life
Clinical Advice & FAQs
Billing Guidance
Is C83.30 a billable ICD-10 code?
Yes, C83.30 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.30?
Clinical documentation must specify the nature of Diffuse large B-cell lymphoma, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference